| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |